Figure 6From: Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model qRT-PCR of IL-17a and TNF-α. Significantly lower expression of IL-17a and TNF-α transcripts can be seen in the eyes treated with TSG-6 compared with the controls. *P < 0.05.Back to article page